City of Hope Vaccine Experts Report Positive Results on Phase 1 Trial of Personalized Vaccine for Lymphoplasmacytic Lymphoma
September 20, 2024
September 20, 2024
DUARTE, California, Sept. 20 -- City of Hope issued the following news release:
* * *
Data demonstrates safety and efficacy of early intervention therapy against a rare cancer
* * *
A team of researchers from City of Hope(R), one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that fe . . .
* * *
Data demonstrates safety and efficacy of early intervention therapy against a rare cancer
* * *
A team of researchers from City of Hope(R), one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that fe . . .